{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:14:16Z","timestamp":1794377656155,"version":"4.9.0"},"reference-count":130,"publisher":"Oxford University Press (OUP)","issue":"23","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart transplantation is advocated in selected patients with advanced heart failure in the absence of contraindications. Principal challenges in heart transplantation centre around an insufficient and underutilized donor organ pool, the need to individualize titration of immunosuppressive therapy, and to minimize late complications such as cardiac allograft vasculopathy, malignancy, and renal dysfunction. Advances have served to increase the organ donor pool by advocating the use of donors with underlying hepatitis C virus infection and by expanding the donor source to use hearts donated after circulatory death. New techniques to preserve the donor heart over prolonged ischaemic times, and enabling longer transport times in a safe manner, have been introduced. Mechanical circulatory support as a bridge to transplantation has allowed patients with advanced heart failure to avoid progressive deterioration in hepato-renal function while awaiting an optimal donor organ match. The management of the heart transplantation recipient remains a challenge despite advances in immunosuppression, which provide early gains in rejection avoidance but are associated with infections and late-outcome challenges. In this article, we review contemporary advances and challenges in this field to focus on donor recovery strategies, left ventricular assist devices, and immunosuppressive monitoring therapies with the potential to enhance outcomes. We also describe opportunities for future discovery to include a renewed focus on long-term survival, which continues to be an area that is under-studied and poorly characterized, non-human sources of organs for transplantation including xenotransplantation as well as chimeric transplantation, and technology competitive to human heart transplantation, such as tissue engineering.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehac204","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T07:10:28Z","timestamp":1649920228000},"page":"2237-2246","source":"Crossref","is-referenced-by-count":62,"title":["Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3085-167X","authenticated-orcid":false,"given":"Maria Generosa","family":"Crespo-Leiro","sequence":"first","affiliation":[{"name":"Department of Cardiology, Complexo Hospitalario Universitario A Coru\u00f1a (CHUAC), Instituto de Investigaci\u00f3n Biomedica A Coru\u00f1a (INIBIC), Centro de Investigacion Biomedica en Red Cardiovascular (CIBERCV) , As Xubias 84, 15006 A Coru\u00f1a , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Costanzo","sequence":"additional","affiliation":[{"name":"Advocate Heart Institute , Naperville, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-341X","authenticated-orcid":false,"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, University of Copenhagen , Copenhagen , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K","family":"Khush","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Stanford University School of Medicine , Stanford, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S","family":"Macdonald","sequence":"additional","affiliation":[{"name":"Heart Transplant Unit, St Vincent\u2019s Hospital , Sydney , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Potena","sequence":"additional","affiliation":[{"name":"Heart Failure and Transplant Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Utah , Salt Lake City, UT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8054-8150","authenticated-orcid":false,"given":"Andreas","family":"Zuckermann","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep R","family":"Mehra","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Brigham and Women\u2019s Hospital, and Harvard Medical School , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"2022061400001178600_ehac204-B1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2022061400001178600_ehac204-B2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report\u20142019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B3","doi-asserted-by":"crossref","first-page":"e019655","DOI":"10.1161\/JAHA.120.019655","article-title":"National trends in heart donor usage rates: are we efficiently transplanting more hearts?","volume":"10","author":"Dharmavaram","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2022061400001178600_ehac204-B4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.healun.2018.09.017","article-title":"Predicted heart mass is the optimal metric for size match in heart transplantation","volume":"38","author":"Kransdorf","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.healun.2020.07.010","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics","volume":"39","author":"Khush","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The registry of the international society for heart and lung transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B7","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1111\/j.1600-6143.2011.03744.x","article-title":"Impact of donor left ventricular hypertrophy on survival after heart transplant","volume":"11","author":"Pinzon O","year":"2011","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.healun.2011.01.721","article-title":"RADIAL: a novel primary graft failure risk score in heart transplantation","volume":"30","author":"Segovia","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.healun.2011.11.005","article-title":"Donor scoring system for heart transplantation and the impact on patient survival","volume":"31","author":"Smits","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B10","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMc1802706","article-title":"The drug-intoxication epidemic and solid-organ transplantation","volume":"378","author":"Mehra","year":"2018","journal-title":"N Engl J Med"},{"key":"2022061400001178600_ehac204-B11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.healun.2020.03.004","article-title":"Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement","volume":"39","author":"Aslam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"2022061400001178600_ehac204-B13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.healun.2009.05.031","article-title":"Utility of virtual crossmatch in sensitized patients awaiting heart transplantation","volume":"28","author":"Stehlik","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.healun.2018.01.1291","article-title":"The management of antibodies in heart transplantation: an ISHLT consensus document","volume":"37","author":"Kobashigawa","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B15","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1111\/j.1600-6143.2012.04258.x","article-title":"Lung and heart allocation in the United States","volume":"12","author":"Colvin-Adams","year":"2012","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.healun.2013.03.015","article-title":"Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit-based heart allocation","volume":"32","author":"Smits","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B17","article-title":"Adult heart allocation 2018","author":"U.S. Department of Health & Human Services"},{"key":"2022061400001178600_ehac204-B18","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1093\/eurheartj\/ehx699","article-title":"Heart Transplantation in Spain: a review of the heart transplant programme in Spain from its beginning in 1984 by Marisa Crespo-Leiro MD","volume":"38","author":"Crespo-Leiro","year":"2017","journal-title":"Eur Heart J"},{"key":"2022061400001178600_ehac204-B19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/ajt.15816","article-title":"New French heart allocation system: comparison with Eurotransplant and US allocation systems","volume":"20","author":"Dorent","year":"2020","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00007890-198804000-00001","article-title":"Principles of solid-organ preservation by cold storage","volume":"45","author":"Belzer","year":"1988","journal-title":"Transplantation"},{"key":"2022061400001178600_ehac204-B21","volume-title":"Guide to the quality and safety of organs for transplantation","author":"Europe","year":"2018","edition":"7th ed."},{"key":"2022061400001178600_ehac204-B22","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0003-4975(99)01028-0","article-title":"Heart preservation for transplantation: principles and strategies","volume":"68","author":"Jahania","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"2022061400001178600_ehac204-B23","first-page":"1143","article-title":"Preservation solutions for cardiac and pulmonary donor grafts: a review of the current literature","volume":"6","author":"Latchana","year":"2014","journal-title":"J Thorac Dis"},{"key":"2022061400001178600_ehac204-B24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report\u20142011","volume":"30","author":"Stehlik","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B25","first-page":"25","author":"Dominguez-Gil","year":"2020","journal-title":"Newsletter transplant international figures on donation and transplantation 2019"},{"key":"2022061400001178600_ehac204-B26","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.21037\/jtd-20-1827","article-title":"First clinical experience with the novel cold storage SherpaPak\u2122 system for donor heart transportation","volume":"12","author":"Radakovic","year":"2020","journal-title":"J Thorac Dis"},{"key":"2022061400001178600_ehac204-B27","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.healun.2021.01.398","article-title":"First report of the GUARDIAN registry: an international consortium examining the effect of controlled hypothermic rreservation in heart transplantation","volume":"40","author":"D\u2019Allesandro","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B28","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/S0140-6736(15)60261-6","article-title":"Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomized non-inferiority trial","volume":"385","author":"Ardehali","year":"2015","journal-title":"Lancet"},{"key":"2022061400001178600_ehac204-B29","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cardfail.2021.07.018","article-title":"EXPANDing the donor pool: quantifying the potential impact of a portable organ-care system for expanded criteria heart donation","volume":"27","author":"Jawitz","year":"2021","journal-title":"J Card Fail"},{"key":"2022061400001178600_ehac204-B30","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1038\/s41467-020-16782-9","article-title":"A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation","volume":"11","author":"Nilsson","year":"2020","journal-title":"Nat Commun"},{"key":"2022061400001178600_ehac204-B31","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/S0140-6736(15)60038-1","article-title":"Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series","volume":"385","author":"Dhital","year":"2015","journal-title":"Lancet"},{"key":"2022061400001178600_ehac204-B32","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/ajt.12782","article-title":"Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning","volume":"14","author":"Iyer","year":"2014","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B33","doi-asserted-by":"crossref","first-page":"e005517","DOI":"10.1161\/CIRCHEARTFAILURE.118.005517","article-title":"Heart transplantation with donation after circulatory death","volume":"12","author":"Niederberger","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2022061400001178600_ehac204-B34","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.healun.2021.03.011","article-title":"Heart transplantation following donation after circulatory death: expanding the donor pool","volume":"40","author":"Scheuer","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jacc.2018.12.067","article-title":"Outcomes of donation after circulatory death heart transplantation in Australia","volume":"73","author":"Chew","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022061400001178600_ehac204-B36","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.healun.2016.07.004","article-title":"Functional assessment and transplantation of the donor heart after circulatory death","volume":"35","author":"Messer","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.healun.2018.03.017","article-title":"Human heart transplantation from donation after circulatory-determined death donors using normothermic regional perfusion and cold storage","volume":"37","author":"Messer","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.healun.2019.02.015","article-title":"Successful clinical transplantation of hearts donated after circulatory death using normothermic regional perfusion","volume":"38","author":"Tchana-Sato","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.healun.2021.06.022","article-title":"Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion","volume":"40","author":"Hoffman","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B40","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.healun.2020.10.001","article-title":"A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors","volume":"39","author":"Messer","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B41","author":"TransMedics Announces Publication of OCSTM Liver PROTECT Trial Results in JAMA Surgery"},{"key":"2022061400001178600_ehac204-B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2019.11.002","article-title":"An early investigation of outcomes with the new 2018 donor heart allocation system in the United States","volume":"39","author":"Cogswell","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ejhf.956","article-title":"Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry","volume":"20","author":"Barge-Caballero","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2022061400001178600_ehac204-B44","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.healun.2019.04.003","article-title":"Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices","volume":"38","author":"Yin","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B45","doi-asserted-by":"crossref","first-page":"e007966","DOI":"10.1161\/CIRCHEARTFAILURE.120.007966","article-title":"Bridging with extracorporeal membrane oxygenation under the new heart allocation system: a united network for organ sharing database analysis","volume":"14","author":"Nordan","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2022061400001178600_ehac204-B46","first-page":"971","article-title":"Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients","volume":"40","author":"Mikus","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022061400001178600_ehac204-B47","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/ejcts\/ezy214","article-title":"Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices","volume":"54","author":"Moayedifar","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2022061400001178600_ehac204-B48","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/eurheartj\/ehaa639","article-title":"Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry","volume":"41","author":"Zimpfer","year":"2020","journal-title":"Eur Heart J"},{"key":"2022061400001178600_ehac204-B49","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.2211","article-title":"Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2022061400001178600_ehac204-B50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.acvd.2019.05.004","article-title":"Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation","volume":"112","author":"Petroni","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"2022061400001178600_ehac204-B51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.118.036932","article-title":"Impact of bridge to transplantation with continuous-flow left ventricular assist devices on posttransplantation mortality","volume":"140","author":"Truby","year":"2019","journal-title":"Circulation"},{"key":"2022061400001178600_ehac204-B52","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.healun.2005.07.014","article-title":"Effect of mechanical circulatory support on outcomes after heart transplantation","volume":"25","author":"Drakos","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B53","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device\u2014final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med"},{"key":"2022061400001178600_ehac204-B54","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N Engl J Med"},{"key":"2022061400001178600_ehac204-B55","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.healun.2019.05.008","article-title":"Gene expression profiling and racial disparities in outcomes after heart transplantation","volume":"38","author":"Moayedi","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B56","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.healun.2010.04.010","article-title":"Gene expression profiling and cardiac allograft rejection monitoring: is IMAGE just a mirage?","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B58","doi-asserted-by":"crossref","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med"},{"key":"2022061400001178600_ehac204-B59","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B60","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/CIRCULATIONAHA.120.049098","article-title":"Cell-free DNA to detect heart allograft acute rejection","volume":"143","author":"Agbor-Enoh","year":"2021","journal-title":"Circulation"},{"key":"2022061400001178600_ehac204-B61","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.cell.2013.10.034","article-title":"Temporal response of the human virome to immunosuppression and antiviral therapy","volume":"155","author":"De Vlaminck","year":"2013","journal-title":"Cell"},{"key":"2022061400001178600_ehac204-B62","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/infdis\/jiy452","article-title":"Torque teno virus as a novel biomarker targeting the efficacy of immunosuppression after lung transplantation","volume":"218","author":"Jaksch","year":"2018","journal-title":"J Infect Dis"},{"key":"2022061400001178600_ehac204-B63","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ajt.15145","article-title":"Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation","volume":"19","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B64","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.healun.2017.05.029","article-title":"Building a tissue-based molecular diagnostic system in heart transplant rejection: the heart Molecular Microscope Diagnostic (MMDx) System","volume":"36","author":"Halloran","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B65","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/TP.0b013e31826e19e2","article-title":"Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II)","volume":"94","author":"Crespo-Leiro","year":"2012","journal-title":"Transplantation"},{"key":"2022061400001178600_ehac204-B66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/MOT.0000000000000407","article-title":"Antibody-mediated rejection in heart transplantation: new developments and old uncertainties","volume":"22","author":"Manfredini","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"2022061400001178600_ehac204-B67","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1161\/CIR.0000000000000598","article-title":"Sensitization in heart transplantation: emerging knowledge: a scientific statement from the American Heart Association","volume":"139","author":"Colvin","year":"2019","journal-title":"Circulation"},{"key":"2022061400001178600_ehac204-B68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181a9e89a","article-title":"Intravenous immunoglobulin a natural regulator of immunity and inflammation","volume":"88","author":"Jordan","year":"2009","journal-title":"Transplantation"},{"key":"2022061400001178600_ehac204-B69","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2022061400001178600_ehac204-B70","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1399-0012.2006.00509.x","article-title":"Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin","volume":"20","author":"Leech","year":"2006","journal-title":"Clin Transplant"},{"key":"2022061400001178600_ehac204-B71","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1053-2498(99)00022-4","article-title":"Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation","volume":"18","author":"Pisani","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B72","doi-asserted-by":"crossref","first-page":"II229","DOI":"10.1161\/circ.100.suppl_2.Ii-229","article-title":"Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients","volume":"100","author":"John","year":"1999","journal-title":"Circulation"},{"key":"2022061400001178600_ehac204-B73","doi-asserted-by":"crossref","first-page":"e2635","DOI":"10.1097\/MD.0000000000002635","article-title":"Desensitization using bortezomib and high-dose immunoglobulin increases rate of deceased donor kidney transplantation","volume":"95","author":"Jeong","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2022061400001178600_ehac204-B74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MOT.0000000000000639","article-title":"Desensitization for sensitized patients awaiting heart transplant","volume":"24","author":"Byku","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"2022061400001178600_ehac204-B75","first-page":"199","article-title":"Rituximab therapy for rejection in pediatric heart transplant","volume":"16","author":"Erdogan","year":"2018","journal-title":"Exp Clin Transplant"},{"key":"2022061400001178600_ehac204-B76","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.healun.2004.09.003","article-title":"Treatment of vascular rejection with rituximab in cardiac transplantation","volume":"24","author":"Garrett HE","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B77","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/ctr.12277","article-title":"Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review","volume":"27","author":"Ravichandran","year":"2013","journal-title":"Clin Transplant"},{"key":"2022061400001178600_ehac204-B78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2019.04.056","article-title":"Accelerated allograft vasculopathy with rituximab after cardiac transplantation","volume":"74","author":"Starling","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022061400001178600_ehac204-B79","doi-asserted-by":"crossref","first-page":"e13639","DOI":"10.1111\/ctr.13639","article-title":"Desensitization in heart transplant recipients: who, when, and how","volume":"33","author":"Shah","year":"2019","journal-title":"Clin Transplant"},{"key":"2022061400001178600_ehac204-B80","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteosome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B81","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.healun.2021.05.019","article-title":"Outcomes of pre- heart transplantation desensitization in a series of highly sensitized patients bridged with left ventricular assist devices","volume":"40","author":"Saadi","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B82","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A randomized trial of bortezomib in late antibody-mediated Kidney transplant rejection","volume":"29","author":"Eskandary","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2022061400001178600_ehac204-B83","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/tri.12706","article-title":"Complement inhibition as potential new therapy for antibody-mediated rejection","volume":"29","author":"Eskandary","year":"2016","journal-title":"Transpl Int"},{"key":"2022061400001178600_ehac204-B84","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S1047951119003056","article-title":"Use of the terminal complement inhibitor eculizumab in paediatric heart transplant recipients","volume":"30","author":"Law","year":"2020","journal-title":"Cardiol Young"},{"key":"2022061400001178600_ehac204-B85","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1111\/ajt.15364","article-title":"Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: a randomized trial","volume":"19","author":"Marks","year":"2019","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B86","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/ajt.16420","article-title":"Complement inhibition for prevention of antibody-mediated rejection in immunologically high-risk heart allograft recipients","volume":"21","author":"Patel","year":"2021","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B87","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.transproceed.2012.05.085","article-title":"The efficacy and safety of alemtuzumab and daclizumab versus antithymocyte globulin during organ transplantation: a meta-analysis","volume":"44","author":"Hao","year":"2012","journal-title":"Transplant Proc"},{"key":"2022061400001178600_ehac204-B88","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/TP.0b013e318257ad41","article-title":"Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis","volume":"93","author":"Morgan","year":"2012","journal-title":"Transplantation"},{"key":"2022061400001178600_ehac204-B89","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12844","article-title":"Alemtuzumab (Campath-1H) therapy for refractory rejections in pediatric heart transplant recipients","volume":"21","author":"Das","year":"2017","journal-title":"Pediatr Transplant"},{"key":"2022061400001178600_ehac204-B90","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1074248419841635","article-title":"Alemtuzumab induction versus conventional Immunosuppression in heart transplant recipients","volume":"24","author":"Gale","year":"2019","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"2022061400001178600_ehac204-B91","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.healun.2007.04.012","article-title":"Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection","volume":"26","author":"Woodside","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B92","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/TP.0000000000003505","article-title":"Daratumumab for antibody-mediated rejection in heart transplant\u2014a novel therapy: successful treatment of antibody-mediated rejection","volume":"105","author":"Agudo C","year":"2021","journal-title":"Transplantation"},{"key":"2022061400001178600_ehac204-B93","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The international society of heart and lung transplantation guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B94","doi-asserted-by":"crossref","first-page":"e14333","DOI":"10.1111\/ctr.14333","article-title":"Extracorporeal photopheresis and its role in heart transplant rejection: prophylaxis and treatment","volume":"35","author":"Slomovich","year":"2021","journal-title":"Clin Transplant"},{"key":"2022061400001178600_ehac204-B95","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/ajt.15584","article-title":"Belatacept-based immunosuppression: a calcineurin inhibitor-sparing regimen in heart transplant recipients","volume":"20","author":"Launay","year":"2020","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40472-021-00331-4","article-title":"IL-6 directed therapy in transplantation","volume":"8","author":"Miller","year":"2021","journal-title":"Curr Transplant Rep"},{"key":"2022061400001178600_ehac204-B97","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2022061400001178600_ehac204-B98","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"2022061400001178600_ehac204-B99","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-fifth adult heart transplantation report-2018; focus theme: multiorgan transplantation","volume":"37","author":"Khush","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cardfail.2020.03.002","article-title":"Combined heart-kidney transplant versus sequential kidney transplant in heart transplant recipients","volume":"26","author":"Gallo","year":"2020","journal-title":"J Card Fail"},{"key":"2022061400001178600_ehac204-B101","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.healun.2019.06.004","article-title":"Impact of combined heart and lung transplantation on bronchiolitis obliterans syndrome, cardiac allograft vasculopathy, and long-term survival","volume":"38","author":"Kitai","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B102","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.healun.2007.08.011","article-title":"Combined heart-kidney transplantation: the University of wisconsin experience","volume":"26","author":"Hermsen","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B103","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1111\/ajt.13870","article-title":"Liver allograft provides immunoprotection for the cardiac allograft in combined heart\u2013liver transplantation","volume":"16","author":"Wong","year":"2016","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B104","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jacc.2021.01.013","article-title":"Heart-after-liver transplantation attenuates rejection of cardiac allografts in sensitized patients","volume":"77","author":"Daly","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022061400001178600_ehac204-B105","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/j.healun.2021.01.716","article-title":"Combined heart-lung transplantation: UNOS data analysis for long term survival outcome","volume":"40","author":"Suryapalam","year":"2021","journal-title":"J Heart Lung Tranplant"},{"key":"2022061400001178600_ehac204-B106","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1600-6143.2007.01902.x","article-title":"Heart retransplantation","volume":"7","author":"Johnson","year":"2007","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B107","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/tri.13289","article-title":"Heart re-transplantation in Eurotransplant","volume":"31","author":"Smits","year":"2018","journal-title":"Transpl Int"},{"key":"2022061400001178600_ehac204-B108","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The registry of the international society for heart and lung transplantation: thirty-third adult heart transplantation report\u20142016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21037\/acs.2018.01.09","article-title":"Outcomes and survival following heart retransplantation for cardiac allograft failure: a systematic review and meta-analysis","volume":"7","author":"Rizvi","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"2022061400001178600_ehac204-B110","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.healun.2020.04.019","article-title":"Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement","volume":"39","author":"Holm","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B111","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1111\/ajt.16138","article-title":"Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic","volume":"20","author":"Galvan","year":"2020","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B112","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhep.2020.05.023","article-title":"An international multicenter study of protocols for liver transplantation during a pandemic: a case for quadripartite equipoise","volume":"73","author":"Chew","year":"2020","journal-title":"J Hepatol"},{"key":"2022061400001178600_ehac204-B113","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1111\/ajt.16550","article-title":"Mortality among solid organ waitlist candidates during COVID-19 in the United States","volume":"21","author":"Miller","year":"2021","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B114","volume-title":"Deceased donor and recipient selection for cardiothoracic transplantation during the COVID-19 pandemic. Recommendations from the ISHLT COVID-19 Task Force","author":"ISHLT task force"},{"key":"2022061400001178600_ehac204-B115","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1111\/ajt.16091","article-title":"Management of heart transplant candidates in the time of COVID-19 pandemic: looking for answers","volume":"20","author":"Pascale","year":"2020","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B116","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1111\/ajt.16532","article-title":"Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B117","doi-asserted-by":"crossref","first-page":"e13664","DOI":"10.1111\/tid.13664","article-title":"Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation","volume":"23","author":"de la Villa","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2022061400001178600_ehac204-B118","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jchf.2020.10.009","article-title":"COVID-19 in heart transplant recipients: a multicenter analysis of the northern Italian outbreak","volume":"9","author":"Bottio","year":"2021","journal-title":"JACC Heart failure"},{"key":"2022061400001178600_ehac204-B119","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.healun.2021.05.006","article-title":"Coronavirus disease 2019 in heart transplant recipients: risk factors, immunosuppression, and outcomes","volume":"40","author":"Genuardi","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B120","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00392-021-01880-5","article-title":"Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients","volume":"110","author":"Schramm","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2022061400001178600_ehac204-B121","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ajt.16775","article-title":"Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients","volume":"22","author":"Del Bello","year":"2022","journal-title":"Am J Transplant"},{"key":"2022061400001178600_ehac204-B122","doi-asserted-by":"crossref","first-page":"e13705","DOI":"10.1111\/tid.13705","article-title":"Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients","volume":"23","author":"Aslam","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"2022061400001178600_ehac204-B123","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/TP.0000000000003908","article-title":"Two doses of SARS-CoV-2 vaccines reduce risk of death due to COVID-19 in solid organ transplant recipients: preliminary outcomes from a UK registry linkage analysis","volume":"105","author":"Ravanan","year":"2021","journal-title":"Transplantation"},{"key":"2022061400001178600_ehac204-B124","doi-asserted-by":"crossref","first-page":"e265\u2013","DOI":"10.1097\/TP.0000000000003907","article-title":"Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients","volume":"105","author":"Qin","year":"2021","journal-title":"Transplantation"},{"key":"2022061400001178600_ehac204-B125","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S0140-6736(17)33093-3","article-title":"Heart transplantation at 50","volume":"390","author":"Mehra","year":"2017","journal-title":"Lancet"},{"key":"2022061400001178600_ehac204-B126","first-page":"1","article-title":"Whole heart engineering: advances and challenges","volume":"211","author":"Morrissey","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"2022061400001178600_ehac204-B127","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.healun.2017.10.010","article-title":"The scourge and enigmatic journey of cardiac allograft vasculopathy","volume":"36","author":"Mehra","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2022061400001178600_ehac204-B128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ejhf.1792","article-title":"Gut dysbiosis and heart failure: navigating the universe within","volume":"22","author":"Madan","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022061400001178600_ehac204-B129","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2022.01.006","article-title":"Cardiac xenotransplantation: rebirth amidst an uncertain future","author":"Mehra","year":"2022","journal-title":"J Card Fail"},{"key":"2022061400001178600_ehac204-B130","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3389\/fimmu.2020.00631","article-title":"Transplanting marginal organs in the era of modern machine perfusion and advanced organ monitoring","volume":"11","author":"Resch","year":"2020","journal-title":"Front Immunol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/23\/2237\/44046641\/ehac204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/23\/2237\/44046641\/ehac204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:28:27Z","timestamp":1700422107000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/23\/2237\/6571226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":130,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,4,20]]},"published-print":{"date-parts":[[2022,6,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac204","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,14]]},"published":{"date-parts":[[2022,4,20]]}}}